Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    US FDA extends review of AstraZeneca’s experimental breast cancer pill

    Picture of AstraZeneca logoAstraZeneca
    27/05/2026 07:20
    US FDA extends review of AstraZeneca’s experimental breast cancer pill
    May 27 (Reuters) - AstraZeneca AZN.L said on Wednesday the U.S. Food and Drug Administration has extended its review deadline for its experimental breast cancer pill camizestrant to assess additional data.

    (Reporting by Ankita Bora in Bengaluru)
    ((Ankita.Bora@thomsonreuters.com))

    Recent news on AstraZeneca

    See all news